Johnson & Johnson Bumps Up Guidance as Sales Rise
Johnson & Johnson Bumps Up Guidance as Sales Rise
The drug and medical-device maker raised its forecast for the year after recording higher sales in the second quarter.
BlackRock Soars to $15.3 Trillion in Assets
Chip-Machine Supplier ASML Raises Guidance Again on Unrelenting AI Demand
The company lifted its annual sales guidance for the second time and said it would boost output of its semiconductor-making machines in the coming years.
Tech Futures Rise With Nasdaq At Key Level; Oil Pushes Above $80
Healthcare Bellwether J&J Beats And Raises, But Shares Dip
Tech Futures Rise With Nasdaq At Key Level; Oil Hits $80
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
Chip-Machine Supplier ASML Raises Guidance Again on Unrelenting AI Demand
By Caitlin McCabe and Jack Pitcher
Maersk Lifts Guidance on Strong Demand, Higher Freight Rates
Morgan Stanley's price target implies that shares of Johnson & Johnson could rise another 17%.
Macy's Lifts Outlook as Turnaround Continues Taking Hold
ASML, Johnson & Johnson, PayPal lead early movers on news.
